Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 2.37 is 76% below its 5-year average of 9.90, near the low end of its 5-year range (2.37–23.15).
As of the fiscal period ended Tuesday, June 30, 2026. 46.75% below its 12-month average of 4.45.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.37.
CURRENT RATIO
2.37
CURRENT RATIO AVG TTM
4.45
CURRENT RATIO AVG 3Y
7.28
CURRENT RATIO AVG 5Y
9.90
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-46.75%
CURRENT VS 3Y AVG
-67.45%
CURRENT VS 5Y AVG
-76.08%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.60
median of 797 covered companies
CURRENT VS SECTOR MEDIAN
-34.18%
vs the sector median at left
Connect Biopharma Holdings Limited
Market Cap
$60.05M
Current Ratio
2.37
TTM Avg
4.45
3Y Avg
7.28
5Y Avg
9.90
Market Cap
$61.12M
Current Ratio
10.98
TTM Avg
17.43
3Y Avg
9.10
5Y Avg
12.08
Market Cap
$63.16M
Current Ratio
9.90
TTM Avg
11.46
3Y Avg
13.71
5Y Avg
15.39
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Connect Biopharma Holdings Limited (CNTB) | $60.05M | 2.37 | 4.45 | 7.28 | 9.90 |
| Xilio Therapeutics, Inc. (XLO)vs › | $60.49M | 4.25 | 2.40 | 3.43 | 5.08 |
| Oncolytics Biotech Inc. (ONCY)vs › | $59.91M | 1.35 | 1.97 | 5.50 | 8.52 |
| Adicet Bio, Inc. (ACET)vs › | $60.11M | 6.71 | 8.38 | 9.61 | 10.03 |
| Kalaris Therapeutics Inc (KLRS)vs › | $61.12M | 10.98 | 17.43 | 9.10 | 12.08 |
| MiNK Therapeutics, Inc. (INKT)vs › | $58.99M | 1.23 | 0.89 | 0.93 | 1.06 |
| Fractyl Health, Inc. (GUTS)vs › | $59.89M | 3.15 | 4.21 | 4.67 | 4.26 |
| Boundless Bio, Inc. (BOLD)vs › | $57.42M | 9.48 | 13.86 | 12.45 | 13.81 |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.16M | 9.90 | 11.46 | 13.71 | 15.39 |
| Alps Group Inc (ALPS)vs › | $63.23M | 0.36 | 0.31 | 0.29 | 1.05 |
Current Ratio
2.37
Quick Ratio
2.37
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 2.37 |
| 2025-12-31 | 3.74 |
| 2025-06-30 | 7.24 |
| 2024-12-31 | 11.46 |
| 2024-06-30 | 12.04 |
| 2023-12-31 | 4.85 |
| 2023-06-30 | 9.26 |
| 2022-12-31 | 9.97 |
| 2022-06-30 | 9.58 |
| 2021-12-31 | 15.30 |
| 2021-06-30 | 23.15 |
| 2020-12-31 | 27.81 |
| 2020-06-30 | 0.00 |
| 2019-12-31 | 13.24 |
| 2019-06-30 | 24.43 |
| 2018-12-31 | 70.44 |
